D-1019-2018 Class II Terminated
FDA drug recall D-1019-2018 was initiated by Hetero Labs, Ltd. - Unit III on Jul 18, 2018 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules. The recall status is terminated (terminated Jul 15, 2021). Affected quantity: 18,288 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 8, 2018
- Initiation Date
- Jul 18, 2018
- Termination Date
- Jul 15, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 18,288 bottles
Product description
Indomethacin Capsules, USP, 50 mg, 100-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854; By: Hetero, Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India; NDC 31722-543-01.
Reason for recall
Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.
Distribution pattern
Nationwide in the USA
Code information
Lot #: E180315, Exp 12/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1019-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026